News

RIBER and NQCP Join Forces to Revolutionize Photonic Technologies

RIBER and NQCP Join Forces to Revolutionize Photonic Technologies

An Exciting Collaboration between RIBER and NQCP

RIBER, a global leader in Molecular Beam Epitaxy (MBE) equipment, has officially embarked on a transformative journey by signing a collaborative partnership agreement with the Novo Nordisk Foundation Quantum Computing Programme (NQCP), a distinguished research center in Denmark.

The Ambitious ROSIE Project

This partnership, which spans three years, aims to industrially qualify the ROSIE process. This innovative platform represents the first 300 mm machine specifically designed for photonics applications while ensuring compatibility with silicon fabrication standards. RIBER's goal is ambitious: to integrate this technology into existing silicon fab production lines.

Strategic Markets for ROSIE

ROSIE is designed to target several key markets, including:

  • Ultra-fast optical communications, especially in the Datacom and Telecom sectors;
  • Optical computing solutions;
  • Advanced photonic quantum technologies.

First Steps in Collaboration

As part of this strategic collaboration, RIBER will deliver the inaugural ROSIE unit to NQCP. This system is anticipated to arrive by the latter half of 2025, set to be installed in a dedicated pilot line focused on photonic technologies. The partnership also emphasizes joint development efforts to refine the ROSIE process, which will be standardized across the new equipment, facilitating prompt production scaling to meet customer expectations swiftly.

Innovation and Support

The ROSIE initiative has been nurtured since 2021, demonstrating RIBER's commitment to leading-edge innovation in the semiconductor sector. This endeavor also receives backing from the Île-de-France Region through its Innov’Up program and Bpifrance, as part of the France 2030 investment initiative aiming to tackle the pressing challenges of the global silicon industry.

A Natural Partnership

RIBER's decision to collaborate with Professor Krogstrup’s team at NQCP was driven by the exceptional scientific environment, expertise, and fervor of the research team. Dr. Jean-Louis Guyaux, RIBER's Chief Technology Officer, expressed confidence in this partnership, which aims to leverage the joint knowledge for groundbreaking advancements.

Additionally, Annie Geoffroy, RIBER's Chairwoman and CEO, emphasized the significance of this collaboration, highlighting the strategic advantage of tying up with a leading lab focused on integrated silicon photonics. The partnership is poised to accelerate the development of innovative processes, addressing increasing market demands for higher performance, compact size, and better energy efficiency, all while enhancing RIBER's innovative capacity.

A Catalyst for European Innovation

This partnership positions RIBER as a formidable force within the European ecosystem dedicated to applied photonics research. It illustrates the capability of a French small to medium enterprise (SME) to present sophisticated technology on a global level, showcasing the immense potential of cross-industry collaborations between science and industry to shape future advancements.

As Annie Geoffroy concluded, this partnership initiates the industrialization phase for ROSIE, marking a proud moment for RIBER as a pioneer technology emerges to serve as a fundamental component for next-generation quantum technologies.

About NQCP

The Novo Nordisk Foundation Quantum Computing Programme (NQCP) is an innovative research initiative backed by the Novo Nordisk Foundation, in conjunction with the Niels Bohr Institute at the University of Copenhagen. The program seeks to develop fault-tolerant quantum computing hardware and algorithms aimed at resolving intricate challenges within life sciences. Its interdisciplinary approach diversifies qubit technologies through collaborations with both academic and industrial partners while also establishing the Quantum Foundry Copenhagen – a dedicated facility focusing on high-precision quantum component manufacturing.

About RIBER

Since its establishment in 1964, RIBER has become the global market leader in MBE equipment. Their contributions extend to designing and producing state-of-the-art equipment for the semiconductor industry while providing essential support services to maintain optimal operational performance. RIBER's innovations play a vital role across various applications, including photonics, advanced electronics, telecommunications, and more, reaffirming its status as an innovative enterprise recognized by BPI France. RIBER is publicly traded on the Euronext Growth Paris market under the ticker: Paris:RIB.

Contact Information

RIBER
Annie Geoffroy | tel: +33 (0)1 39 96 65 00 | invest@riber.com
ACTUS FINANCE & COMMUNICATION
Cyril Combe | tel: +33 (0)1 53 67 36 36 | ccombe@actus.fr

Frequently Asked Questions

What is the ROSIE project?

The ROSIE project focuses on developing a 300 mm machine dedicated to photonics that is compatible with silicon fabs.

Which markets does the ROSIE platform target?

The ROSIE platform targets ultra-fast optical communications, optical computing, and quantum technologies.

When will the first ROSIE unit be delivered?

The first ROSIE unit is scheduled for delivery in the second half of 2025.

Who is partnering with RIBER in this initiative?

RIBER is partnering with the Novo Nordisk Foundation Quantum Computing Programme (NQCP) for this initiative.

What support has ROSIE received?

ROSIE has received backing from the Île-de-France Region and Bpifrance under the France 2030 investment plan.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 294

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 152

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 138

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 218

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Tennessee's Bold Lung Cancer Trial Signals Innovation

Updated Category News Views 119

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

Continue Reading
Air Sealing First: Boosting Home Comfort & Efficiency

Updated Category News Views 157

Everyone wants a cozy, energy-efficient home, right? Well, the first step to achieving that might just surprise you. Forget about shoving more insulation into the walls for a second; air sealing should be your starting line. That's the drum Insulation Expert Mike Mancuso is beating, and he's got a point worth considering before you touch another insulation panel. Cracking...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 75

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 289

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Community in Shock After Fatal Bakersfield Shooting

Updated Category News Views 136

The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 206

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading

Top 5 Most Recently Viewed Articles

Sobi's Share Increase and Its Impact on Business Growth

Updated Category News Views 202

Sobi's Growth through Share Increases In a recent announcement, Swedish Orphan Biovitrum AB (publ) has revealed a significant increase in its total number of shares and votes. As of the latest update, the total number of shares amounts to 357,412,837, including 356,000,049 common shares and 1,412,788 class C shares. This increase in shares is primarily attributed to the...

Continue Reading
Hain Celestial's Q1 Results Show Improvement Despite Losses

Updated Category News Views 116

Hain Celestial Group Reports Strong Fiscal First Quarter Results Hain Celestial Group, Inc. (NASDAQ: HAIN), a prominent global health and wellness company, has recently shared its financial performance for the first quarter of the fiscal year. Despite facing challenges, the company indicates a clear trajectory towards recovery and improvement in its business operations....

Continue Reading
Orca Energy Group Provides Key Updates on Operations and Finances

Updated Category News Views 181

Overview of Orca Energy Group's Operational Update Orca Energy Group Inc. (TSX-V: ORC.A, ORC.B) is excited to announce significant updates regarding its operations and financial performance. The company, which operates in natural gas development, continues its focus on the production and supply of gas in Tanzania through its subsidiary, PanAfrican Energy Tanzania Limited....

Continue Reading
Annexon Encourages Growth with Employee Stock Options Grant

Updated Category News Views 153

Annexon Supports New Talent with Inducement Grants In a recent move to bolster its workforce, Annexon, Inc. (Nasdaq: ANNX), a prominent biopharmaceutical company, has made strides in attracting top talent by offering inducement grants to new employees. This is part of their 2022 Employment Inducement Award Plan. The grant is designed to empower its workforce while...

Continue Reading
Don Johnson Receives FAA Wright Brothers Master Pilot Award

Updated Category News Views 320

Honoring Aviation Excellence: FAA Award for Don Johnson Prime Jet, a leader in private jet charters and aircraft management, proudly announces a significant accomplishment of one of its renowned pilots. Don Johnson has been awarded the prestigious Wright Brothers Master Pilot Award by the Federal Aviation Administration (FAA). This distinguished honor is extended to...

Continue Reading